Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;27(3):155-60.
doi: 10.1016/j.sdentj.2015.01.003. Epub 2015 May 27.

Combination of bone allograft, barrier membrane and doxycycline in the treatment of infrabony periodontal defects: A comparative trial

Affiliations

Combination of bone allograft, barrier membrane and doxycycline in the treatment of infrabony periodontal defects: A comparative trial

Ashish Agarwal et al. Saudi Dent J. 2015 Jul.

Abstract

Aim: The purpose of the present study was to compare the regenerative potential of noncontained periodontal infrabony defects treated with decalcified freeze-dried bone allograft (DFDBA) and barrier membrane with or without local doxycycline.

Methods: This study included 48 one- or two-wall infrabony defects from 24 patients (age: 30-65 years) seeking treatment for chronic periodontitis. Defects were randomly divided into two groups and were treated with a combination of DFDBA and barrier membrane, either alone (combined treatment group) or with local doxycycline (combined treatment + doxycycline group). At baseline (before surgery) and 3 and 6 months after surgery, the pocket probing depth (PPD), clinical attachment level (CAL), radiological bone fill (RBF), and alveolar height reduction (AHR) were recorded. Analysis of variance and the Newman-Keuls post hoc test were used for statistical analysis. A two-tailed p-value of less than 0.05 was considered to be statistically significant.

Results: In the combined treatment group, the PPD reduction was 2.00 ± 0.38 mm (32%), CAL gain was 1.25 ± 0.31 mm (17.9%), and RBF was 0.75 ± 0.31 mm (20.7%) after 6 months. In the combined treatment + doxycycline group, these values were 2.75 ± 0.37 mm (44%), 1.5 ± 0.27 mm (21.1%), and 1.13 ± 0.23 mm (28.1%), respectively. AHR values for the groups without and with doxycycline were 12.5% and 9.4%, respectively.

Conclusion: There was no significant difference in the regeneration of noncontained periodontal infrabony defects between groups treated with DFDBA and barrier membrane with or without doxycycline.

Keywords: Bone grafting; Doxycycline; Guided tissue regeneration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pre operative pocket probing depth in DFDBA+ barrier membrane group.
Figure 2
Figure 2
Infra bony defect mesial to 2nd premolar.
Figure 3
Figure 3
Barrier membrane placement over bone graft in defect area.
Figure 4
Figure 4
Pocket probing depth after 6 months in DFDBA+ barrier membrane group.
Figure 5
Figure 5
Pre operative radiograph of DFDBA+ barrier membrane group.
Figure 6
Figure 6
Post operative radiograph of DFDBA+ barrier membrane group.

References

    1. Aimetti M., Romano F., Pigella E., Pranzini F., Debernardi C. Treatment of wide, shallow, and predominantly 1-wall infrabony defects with a bioresorbable membrane: a randomize controlled clinical trial. J. Periodontol. 2005;76:1354–1361. - PubMed
    1. Behfarnia P., Shahabooei M., Mashhadiabbas F., Fakhari E. Comparison of bone regeneration using three demineralized freeze-dried bone allografts: a histological and histomorphometric study in rabbit calvaria. Dent. Res. J. 2012;9:554–560. - PMC - PubMed
    1. Chaturvedi R., Gill A.S., Sikri P. Evaluation of the regenerative potential of 25% doxycycline-loaded biodegradable membrane vs biodegradable membrane alone in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J. Dent. Res. 2008;19:116–123. - PubMed
    1. Chen C.C., Wang H.L., Smith F., Glickman G.N., Shyr Y.N.R. Evaluation of collagen membrane with and without bone grafts in treating periodontal infrabony defects. J. Periodontol. 1995;66:838–847. - PubMed
    1. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors. 2004;22:233–241. - PubMed

LinkOut - more resources